Masakazu Toi (President of the Japanese Breast Cancer Society), Tokyo Metropolitan Komagome Hospital, Japan
Decoding the mechanisms of ADC drugs beyond traditional therapies and their unique impact on the tumor microenvironment, charting new directions for precision treatment in breast cancer.